Ann Arbor area biotech startup lands $34 million to develop kidney ... - AnnArbor.com PDF Print
AnnArbor.com
CytoPherx is developing a device that would be attached to a renal replacement circuit and "is designed to focus on acute systemic inflammation that is not well addressed with currently available therapies," sometimes in patients whose inflammation is

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.